Neurobiology of early psychosis
暂无分享,去创建一个
M. Keshavan | C. Pantelis | R. Zipursky | S. Wood | G. Berger | S. Wood
[1] W. Heiden,et al. Course and Outcome of Schizophrenia , 2007 .
[2] C. Pantelis,et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. , 2003, The American journal of psychiatry.
[3] C. Pantelis,et al. Spatial working memory ability is a marker of risk-for-psychosis , 2003, Psychological Medicine.
[4] M. Yücel,et al. Early and Late Neurodevelopmental Disturbances in Schizophrenia and Their Functional Consequences , 2003, The Australian and New Zealand journal of psychiatry.
[5] Hans Stassen,et al. How specific are deficits in mismatch negativity generation to schizophrenia? , 2003, Biological Psychiatry.
[6] D. Nutt,et al. Increased sympathetic response to standing in panic disorder , 2003, Psychiatry Research.
[7] W. Strik,et al. Reduced hippocampal anisotropy related to anteriorization of alpha EEG in schizophrenia , 2003, Neuroreport.
[8] J. Callicott. An expanded role for functional neuroimaging in schizophrenia , 2003, Current Opinion in Neurobiology.
[9] S. Catts. Book Review: Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services , 2003 .
[10] S. Andersen. Trajectories of brain development: point of vulnerability or window of opportunity? , 2003, Neuroscience & Biobehavioral Reviews.
[11] C. Pantelis,et al. Verbal paired associate learning in schizophrenia, schizophreniform psychosis and ‘at risk’ mental state , 2003, Schizophrenia Research.
[12] J. Lieberman,et al. Antipsychotic treatment effects on progression of brain pathomorphology in first episode schizophrenia , 2003, Schizophrenia Research.
[13] Hok Pan Yuen,et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group , 2003, Schizophrenia Research.
[14] C. Pantelis,et al. Progressive frontal lobe reduction in first episode psychosis , 2003, Schizophrenia Research.
[15] C. Pantelis,et al. Melbourne high risk study: Olfactory identification ability is impaired in individuals at ultra high-risk for psychosis who later develop schizophrenia , 2003, Schizophrenia Research.
[16] R. Heinrichs,et al. Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis , 2003, Psychiatry Research: Neuroimaging.
[17] John Suckling,et al. For personal use. Only reproduce with permission from The Lancet Publishing Group. Effect of sunlight and season on serotonin turnover in the brain , 2002 .
[18] C. Pantelis,et al. Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. , 2002, American journal of medical genetics.
[19] B. Cornblatt. The New York high risk project to the Hillside recognition and prevention (RAP) program. , 2002, American journal of medical genetics.
[20] M. Keshavan,et al. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia , 2002, Schizophrenia Research.
[21] Ravi S. Menon,et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.
[22] R. Kahn,et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. , 2002, Archives of general psychiatry.
[23] Beatriz Luna,et al. A preliminary functional magnetic resonance imaging study in offspring of schizophrenic parents , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[24] Hok Pan Yuen,et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.
[25] P. Michie,et al. Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders , 2002, Biological Psychiatry.
[26] J. Klosterkötter,et al. Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic , 2002, British Journal of Psychiatry.
[27] Martha E Shenton,et al. Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. , 2002, Archives of general psychiatry.
[28] Daniel R Weinberger,et al. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? , 2002, Archives of general psychiatry.
[29] Brian Sheitman,et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. , 2002, The American journal of psychiatry.
[30] C. Pantelis,et al. Implications of Lipid Biology for the Pathogenesis of Schizophrenia , 2002, The Australian and New Zealand journal of psychiatry.
[31] Richie Poulton,et al. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. , 2002, Archives of general psychiatry.
[32] C. Pantelis,et al. Visuospatial memory and learning in first-episode schizophreniform psychosis and established schizophrenia: a functional correlate of hippocampal pathology? , 2002, Psychological Medicine.
[33] Sandeep D. Jaipurkar,et al. Structural brain differences between never-treated patients with schizophrenia, with and without dyskinesia, and normal control subjects: a magnetic resonance imaging study. , 2002, Archives of general psychiatry.
[34] W. Heiden,et al. Precipitation and determination of the onset and course of schizophrenia by substance abuse — a retrospective and prospective study of 232 population-based first illness episodes , 2002, Schizophrenia Research.
[35] Ron Kikinis,et al. Association between smaller left posterior superior temporal gyrus volume on magnetic resonance imaging and smaller left temporal P300 amplitude in first-episode schizophrenia. , 2002, Archives of general psychiatry.
[36] P. McGorry,et al. Implementing Early Intervention in Psychosis: A Guide to Establishing Psychosis Services , 2002 .
[37] Dennis Velakoulis,et al. Anterior cingulate activation during Stroop task performance: a PET to MRI coregistration study of individual patients with schizophrenia. , 2002, The American journal of psychiatry.
[38] S. Lawrie,et al. Sustained attention in young people at high risk for schizophrenia , 2002, Psychological Medicine.
[39] S. Lawrie,et al. Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study , 2002, British Journal of Psychiatry.
[40] R. Kahn,et al. Volume changes in gray matter in patients with schizophrenia. , 2002, The American journal of psychiatry.
[41] J. Sweeney,et al. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia , 2002, Schizophrenia Research.
[42] R. Murray,et al. Schizophrenia: a neurodevelopmental or neurodegenerative disorder? , 2002 .
[43] J. Lieberman,et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches , 2001, Biological Psychiatry.
[44] Daniel R. Weinberger,et al. Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.
[45] John Polich,et al. P300 asymmetry in schizophrenia: a meta-analysis , 2001, Psychiatry Research.
[46] Patricia Desmond,et al. A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia , 2001, Schizophrenia Research.
[47] P. Styles,et al. Developmental and regional distribution of aspartoacylase in rat brain tissue , 2001, Journal of neurochemistry.
[48] F. Jessen,et al. Amplitude reduction of the mismatch negativity in first-degree relatives of patients with schizophrenia , 2001, Neuroscience Letters.
[49] Adrian M. Owen,et al. Cognitive Deficits in Brain Disorders , 2001 .
[50] L. Rangel,et al. Childhood chronic fatigue syndrome. , 2001, The American journal of psychiatry.
[51] A. Malla,et al. Untreated initial psychosis. , 2001, The American journal of psychiatry.
[52] W. Kaiser,et al. Cerebral phosphate metabolism in first-degree relatives of patients with schizophrenia. , 2001, The American journal of psychiatry.
[53] S. Lawrie,et al. Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia , 2001, Biological Psychiatry.
[54] R. McCarley,et al. A review of MRI findings in schizophrenia , 2001, Schizophrenia Research.
[55] N. Andreasen,et al. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia , 2001, Biological Psychiatry.
[56] J. Cohen,et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. , 2001, Archives of general psychiatry.
[57] R. Buchanan,et al. A separate disease within the syndrome of schizophrenia. , 2001, Archives of general psychiatry.
[58] Alessandro Bertolino,et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia , 2001, Biological Psychiatry.
[59] D. Javitt,et al. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.
[60] J. Lieberman,et al. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern. , 2000, Archives of general psychiatry.
[61] A. Caspi,et al. Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. , 2000, Archives of general psychiatry.
[62] C. Pantelis,et al. Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. , 2000, The Australian and New Zealand journal of psychiatry.
[63] R. Coppola,et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.
[64] P. Liddle,et al. Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus , 2000, British Journal of Psychiatry.
[65] P. McGorry,et al. Insight in psychosis. , 2000, The Harvard mental health letter.
[66] R. McCarley,et al. Lateralized P3 deficit in schizotypal personality disorder , 2000, Biological Psychiatry.
[67] Walter Ritter,et al. Associated deficits in mismatch negativity generation and tone matching in schizophrenia , 2000, Clinical Neurophysiology.
[68] M. Keshavan,et al. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings—part II , 2000, Biological Psychiatry.
[69] M. Egan,et al. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. , 2000, Archives of general psychiatry.
[70] Matcheri S Keshavan,et al. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.
[71] I. Gottesman,et al. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. , 2000, The American journal of psychiatry.
[72] M. Baslow,et al. Functions of N‐Acetyl‐l‐Aspartate and N‐Acetyl‐l‐Aspartylglutamate in the Vertebrate Brain , 2000, Journal of neurochemistry.
[73] J. Lieberman,et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.
[74] Tyrone D. Cannon,et al. P300 subcomponent abnormalities in schizophrenia: III. Deficits in unaffected siblings of schizophrenic probands , 2000, Biological Psychiatry.
[75] Margaret Niznikiewicz,et al. The effect of family status and schizotypy on electrophysiologic measures of attention and semantic processing , 2000, Biological Psychiatry.
[76] Adolf Pfefferbaum,et al. Trait and state aspects of p300 amplitude reduction in schizophrenia: a retrospective longitudinal study , 2000, Biological Psychiatry.
[77] G. Jackson,et al. Neurobiological findings in early phase schizophrenia , 2000, Brain Research Reviews.
[78] Dieter F. Braus,et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia , 2000, Schizophrenia Research.
[79] P. Maruff,et al. Magnetic Resonance Spectroscopy and Schizophrenia: What have we Learnt? , 2000, The Australian and New Zealand journal of psychiatry.
[80] P. Maruff,et al. The nature of the memory deficit in schizophrenia , 2000, Schizophrenia Research.
[81] E. Bullmore,et al. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[82] J. Newcomer,et al. NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.
[83] P. Falkai,et al. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". , 1999, Journal of psychiatric research.
[84] L. DeLisi,et al. Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia. , 1999, The American journal of psychiatry.
[85] N. Andreasen,et al. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. , 1999, The American journal of psychiatry.
[86] E. Johnstone,et al. Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS) , 1999, Psychological Medicine.
[87] M. Keshavan,et al. Brain maturational processes and delayed onset in schizophrenia , 1999, Development and Psychopathology.
[88] R. Kahn,et al. Memory impairment in schizophrenia: a meta-analysis. , 1999, The American journal of psychiatry.
[89] D. Arnold,et al. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. , 1999, Archives of neurology.
[90] Jane S. Paulsen,et al. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. , 1999, Archives of general psychiatry.
[91] M Takigawa,et al. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. , 1999, The American journal of psychiatry.
[92] Robert Bartha,et al. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients , 1999, Biological Psychiatry.
[93] Steven Warach,et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.
[94] Karl J. Friston,et al. Abnormal Cingulate Modulation of Fronto-Temporal Connectivity in Schizophrenia , 1999, NeuroImage.
[95] P. Goldman-Rakic,et al. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. , 1998, Archives of general psychiatry.
[96] O Salonen,et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. , 1998, Archives of general psychiatry.
[97] D. Javitt,et al. Effects of clozapine on auditory event-related potentials in schizophrenia , 1998, Biological Psychiatry.
[98] A. Catafau,et al. The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-naive and neuroleptic-free schizophrenic female patients , 1998, Biological Psychiatry.
[99] T Sigmundsson,et al. Brain changes in schizophrenia , 1998, British Journal of Psychiatry.
[100] Konstantine K. Zakzanis,et al. Neurocognitive Deficit in Schizophrenia: A Quantitative Review of the Evidence , 1998 .
[101] G. Patton,et al. Prediction of psychosis , 1998, British Journal of Psychiatry.
[102] D J Mikulis,et al. Cerebral gray matter volume deficits in first episode psychosis. , 1998, Archives of general psychiatry.
[103] J. Coyle,et al. Evidence for the presence of N-acetylaspartylglutamate in cultured oligodendrocytes and LPS activated microglia , 1998, Brain Research.
[104] T. Robbins,et al. Executive function in first-episode schizophrenia , 1998, Psychological Medicine.
[105] Y. Hirayasu,et al. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment , 1998, Biological Psychiatry.
[106] S. Lawrie,et al. Brain abnormality in schizophrenia , 1998, British Journal of Psychiatry.
[107] Tyrone D. Cannon,et al. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. , 1998, Archives of general psychiatry.
[108] Thomas E. Nichols,et al. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. , 1997, The American journal of psychiatry.
[109] Gregory G. Brown,et al. Review of functional magnetic resonance imaging in schizophrenia , 1997, Schizophrenia Research.
[110] R W Neufeld,et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. , 1997, Archives of general psychiatry.
[111] M S Buchsbaum,et al. Decreased anterior cingulate gyrus metabolic rate in schizophrenia. , 1997, The American journal of psychiatry.
[112] J. Ragland,et al. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study , 1997, Schizophrenia Research.
[113] R. M. Murray,et al. The Maudsley Family Study, II: Endogenous event-related potentials in familial schizophrenia , 1997, Schizophrenia Research.
[114] K O Lim,et al. Cortical gray matter volume deficit in patients with first-episode schizophrenia. , 1996, The American journal of psychiatry.
[115] M. Albus,et al. Neuropsychological impairment in first-episode and chronic schizophrenic patients , 1996, European Archives of Psychiatry and Clinical Neuroscience.
[116] C. Pantelis,et al. What have We Learned from Functional Imaging Studies in Schizophrenia? the Role of Frontal, Striatal and Temporal Areas , 1996, The Australian and New Zealand journal of psychiatry.
[117] J. Coyle,et al. N-Acetylaspartate in neuropsychiatric disorders , 1995, Progress in Neurobiology.
[118] P. Williamson,et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. , 1995, Archives of general psychiatry.
[119] S. Andrews,et al. Brain potential evidence for an auditory sensory memory deficit in schizophrenia. , 1995, The American journal of psychiatry.
[120] M. Keshavan,et al. Changes in caudate volume with neuroleptic treatment , 1994, The Lancet.
[121] J. Ford,et al. ERPs in schizophrenia: Effects of antipsychotic medication , 1994, Biological Psychiatry.
[122] R. Gur,et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. , 1994, Archives of general psychiatry.
[123] Daniel R. Weinberger,et al. Medial temporal lobe structures in schizophrenia: relationship of size to duration of illness , 1994, Schizophrenia Research.
[124] D. Blackwood,et al. Neuropsychological and P300 abnormalities in schizophrenics and their relatives , 1993, Psychological Medicine.
[125] P. Rowlands. Insight in psychosis , 1993, British Journal of Psychiatry.
[126] D. Gadian,et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[127] R Kikinis,et al. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. , 1993, Archives of general psychiatry.
[128] T. Inubushi,et al. Brain lithium concentrations measured with lithium-7 magnetic resonance spectroscopy in patients with affective disorders: Relationship to erythrocyte and serum concentrations , 1993, Biological Psychiatry.
[129] J. Born,et al. Event-related potential correlates of impaired selective attention in children at high risk for schizophrenia , 1992, Biological Psychiatry.
[130] D. Weinberger,et al. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.
[131] L. DeLisi,et al. Neuropsychological functioning of first-episode schizophreniform patients. , 1992, The American journal of psychiatry.
[132] Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia Richard Jed Wyatt NIMH Neuroscience Center, Washington, DC 20032 , 1992, Biological Psychiatry.
[133] R. Wyatt. 13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia , 1991, Schizophrenia Research.
[134] J C Duffy,et al. Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. , 1991, Archives of general psychiatry.
[135] M. Keshavan,et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.
[136] P. Tueting. Electrophysiology of schizophrenia. EEG and ERPs , 1991 .
[137] M. Mintz,et al. Event-related potentials in drug-naive schizophrenic patients , 1991, Biological Psychiatry.
[138] Lynn W. Jelinski,et al. Nuclear magnetic resonance spectroscopy. , 1990, Analytical chemistry.
[139] S. Siris,et al. Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.
[140] S. Stahl,et al. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. , 1988, Archives of general psychiatry.
[141] R. Murray,et al. Is schizophrenia a neurodevelopmental disorder? , 1987, British medical journal.
[142] J. Strauss,et al. The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. , 1987, The American journal of psychiatry.
[143] R Kono,et al. Antibody titres to enterovirus type 70 in the 1981 Indian epidemic of acute haemorrhagic conjunctivitis. , 1981, Lancet.
[144] D. Weinberger,et al. Structural abnormalities in the cerebral cortex of chronic schizophrenic patients. , 1979, Archives of general psychiatry.
[145] T. Crow,et al. CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.
[146] Stephan Arndt,et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. , 2003, The American journal of psychiatry.
[147] J. Sweeney,et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. , 2003, Schizophrenia bulletin.
[148] N. Minshew,et al. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study , 2003, Molecular Psychiatry.
[149] N. Minshew,et al. Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study , 2003, Molecular Psychiatry.
[150] H. Sauer,et al. Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin Card Sorting Test – a fMRI study , 2001, European Archives of Psychiatry and Clinical Neuroscience.
[151] C. Pantelis,et al. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. , 2001, The American journal of psychiatry.
[152] R. Kahn,et al. Volumes of brain structures in twins discordant for schizophrenia. , 2001, Archives of general psychiatry.
[153] A. Jablensky. Course and outcome of schizophrenia and their prediction , 2000 .
[154] J A Frank,et al. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia. , 2000, The American journal of psychiatry.
[155] H. Meltzer,et al. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.
[156] R. Heinrichs,et al. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.
[157] G C Patton,et al. Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.
[158] T. Barnes,et al. Schizophrenia : a neuropsychological perspective , 1996 .
[159] T. McGlashan,et al. Early detection and intervention in schizophrenia: research. , 1996, Schizophrenia bulletin.
[160] S. Kugelmass,et al. Neuropsychological assessment of attention and its pathology in the Israeli cohort. , 1995, Schizophrenia bulletin.
[161] D Friedman,et al. Event-related potentials (ERPs) as indicators of risk for schizophrenia. , 1994, Schizophrenia bulletin.
[162] M E Shenton,et al. P300 topographic asymmetries are present in unmedicated schizophrenics. , 1993, Electroencephalography and clinical neurophysiology.
[163] M. Keshavan,et al. First-episode studies in schizophrenia: criteria and characterization. , 1992, Schizophrenia bulletin.
[164] I. Feinberg. Cortical pruning and the development of schizophrenia. , 1990, Schizophrenia bulletin.
[165] K. Lim,et al. Differing effects of duration of illness on CT findings in alcoholism and schizophrenia. , 1988, Psychopharmacology bulletin.
[166] S. Weintraub. Risk factors in schizophrenia: the Stony Brook High-Risk Project. , 1987, Schizophrenia bulletin.
[167] D. Garver. Methodological issues facing the interpretation of high-risk studies: biological heterogeneity. , 1987, Schizophrenia bulletin.
[168] I. Feinberg,et al. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? , 1982, Journal of psychiatric research.